ctrl K

Watchlist Price Alert

Coeptis Therapeutics Inc. (COEP)

NASDAQ: COEP · Real-Time Price · USD

8.16

-0.07 (-0.85%)

At close: Jun 17, 2025, 3:43 PM

8.21

0.61%

After-hours: Jun 17, 2025, 04:04 PM EDT

Coeptis Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	75K	30.76K	n/a	n/a
Cost of Revenue	1.04M	1M	1M	n/a	964.22K	n/a	n/a
Gross Profit	-1.04M	-1M	-1M	-372K	-933K	n/a	n/a
Operating Income	-10.05M	-21.49M	-34.2M	-14.05M	-6.86M	n/a	n/a
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-10.88M	-21.27M	-37.57M	-13.45M	-9.16M	-2.23K	-7.07K
Net Income	-9.81M	-21.27M	-37.57M	-13.45M	-9.16M	-2.23K	-7.07K
Selling & General & Admin	945.64K	13.82M	33.17M	14.12M	5.78M	n/a	n/a
Research & Development	2.33M	6.67M	20.89K	n/a	3.54K	n/a	n/a
Other Expenses	6.78M	n/a	n/a	n/a	148.19K	n/a	n/a
Operating Expenses	10.05M	20.49M	33.2M	14.12M	5.78M	n/a	n/a
Interest Expense	n/a	-108K	218.41K	187.13K	148.19K	n/a	n/a
Selling & Marketing Expenses	n/a	12.71K	8.33K	2.92K	6.61K	n/a	n/a
Cost & Expenses	-10.05M	21.49M	34.2M	14.12M	6.74M	n/a	n/a
Income Tax Expense	-1.06M	n/a	3.39M	972.92K	-2.15M	n/a	n/a
Shares Outstanding (Basic)	1.93M	25.69M	14.3M	1.02M	20.44M	10.78M	539.06K
Shares Outstanding (Diluted)	1.93M	25.69M	14.3M	1.02M	20.44M	10.78M	539.06K
EPS (Basic)	-5.1	-0.83	-2.87	-13.16	-0.45	-0.00	-0.01
EPS (Diluted)	-5.1	-0.83	-2.87	-13.16	-0.45	-0.00	-0.01
EBITDA	-10.05M	-20.16M	-36.35M	-12.81M	-8.69M	171.86K	-7.07K
EBIT	-11.27M	-21.16M	-37.36M	-13.26M	-9.01M	n/a	-7.07K
Depreciation & Amortization	1.04M	1M	1M	447.41K	323.43K	171.86K	n/a